58 related articles for article (PubMed ID: 15264123)
21. Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.
Karakolios A; Kasapis C; Kallinikidis T; Kalpidis P; Grigoriadis N
Clin Gastroenterol Hepatol; 2003 Nov; 1(6):480-3. PubMed ID: 15017648
[TBL] [Abstract][Full Text] [Related]
22. Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.
Kang MK; Park JG; Lee HJ
Med Princ Pract; 2018; 27(2):197-200. PubMed ID: 29320775
[TBL] [Abstract][Full Text] [Related]
23. Stauffer's syndrome variant associated with renal cell carcinoma.
Giannakos G; Papanicolaou X; Trafalis D; Michaelidis I; Margaritis G; Christofilakis C
Int J Urol; 2005 Aug; 12(8):757-9. PubMed ID: 16174051
[TBL] [Abstract][Full Text] [Related]
24. Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy.
Mignogna MD; Fortuna G; Leuci S; Adamo D; Ruoppo E
Br J Dermatol; 2009 Feb; 160(2):468-70. PubMed ID: 19120335
[No Abstract] [Full Text] [Related]
25. Paraneoplastic cholestasis associated with prostate carcinoma.
Koruk M; Büyükberber M; Savaş C; Kadayifçi A
Turk J Gastroenterol; 2004 Mar; 15(1):53-5. PubMed ID: 15264123
[TBL] [Abstract][Full Text] [Related]
26. [Cholestasis and prostatic carcinoma. Description of a case and review of paraneoplastic cholestasis].
Morís de la Tassa J; Claros González I; García-Alcalde Fernández ML; Antuña Egocheaga A; Argüelles Toraño M
Med Clin (Barc); 1991 Jan; 96(1):22-5. PubMed ID: 2023465
[TBL] [Abstract][Full Text] [Related]
27. [The cutaneous metastasis of prostatic adenocarcinoma. Apropos a case].
Escaf Barmadah S; Capdevila Hernández JM; González Naranjo F
Arch Esp Urol; 1993 Jun; 46(5):426-8. PubMed ID: 8342982
[TBL] [Abstract][Full Text] [Related]
28. Intrahepatic cholestatic jaundice related to administration of ranitidine. A case report with histologic and ultramicroscopic study.
Varriale M; Salvio A; Giannattasio F; d'Errico T; Montone L; Borgia F; Gentile I; Reynaud L; Borgia G; Rossiello R; Visconti M
Minerva Gastroenterol Dietol; 2004 Dec; 50(4):339-43. PubMed ID: 15788990
[TBL] [Abstract][Full Text] [Related]
29. New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
Sciarra A; Cardi A; Dattilo C; Mariotti G; Di Monaco F; Di Silverio F
Int J Clin Pract; 2006 Apr; 60(4):462-70. PubMed ID: 16620361
[TBL] [Abstract][Full Text] [Related]
30. [Update on endoscopic management of malignant obstructive jaundice].
Barinagarrementeria R
Rev Gastroenterol Mex; 2005 Jul; 70 Suppl 1():95-106. PubMed ID: 17469413
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
van der Kwast TH; Hoedemaeker RF; Schröder FH
Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
[TBL] [Abstract][Full Text] [Related]
32. [Non-metastatic intrahepatic cholestasis associated with bronchial adenocarcinoma].
Saintigny P; Spano JP; Tcherakian F; Pailler MC; Breau JL
Ann Med Interne (Paris); 2003 May; 154(3):171-5. PubMed ID: 12910044
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous paraneoplastic syndromes: uncommon presentations.
Thomas I; Schwartz RA
Clin Dermatol; 2005; 23(6):593-600. PubMed ID: 16325068
[TBL] [Abstract][Full Text] [Related]
34. What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate?
Kasibhatla M; Peterson B; Anscher MS
Prostate Cancer Prostatic Dis; 2005; 8(2):167-73. PubMed ID: 15711603
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
